文献库搜索 | GeneLibs

Li(M),Kou(X),Huang(J),Su(Y),Zeng(G),Mo(J),... Inorg Chem 2026-09-14

Metal-oxide semiconductor (MOS) gas sensors are vital for environmental monitoring, yet they face inherent trade-offs am...

Li(Y),Liu(Y),Peng(Y),Tang(J),Li(X) Oncology 2026-00-00

...mOS = 9.0 months vs. 10.0 months, p < 0.05). The common AEs were myelosuppression, hypertension, proteinuria, and hand-f...

Dempke(WCM),Fenchel(K),Sullivan(L),Reck(M) Cancer Drug Resist 2026-00-00

...mOS) relative to monotherapy. However, due to several resistance mechanisms, patients experience disease progression fol...

Li(Y),Liang(C),Feng(Z),Lu(S),Wang(G),Meng(... J Thorac Dis 2026-08-31

...mOS) improved from 4.0 months [95% confidence interval (CI): 4.0-4.0] in the pre-immunotherapy era to 5.0 months (95% CI...

Sun(J),Zhang(Q),Yang(Y),Wu(H),Zhai(W),Li(Y... Transl Lung Cancer Res 2026-08-31

...mOS) following LM diagnosis was 10.2 months [95% confidence interval (CI): 6.2-11.1]. Patients treated with targeted the...

Liao(Z),Huang(J),Liu(H),Zhang(C),Li(T),Wan... Front Immunol 2026-00-00

...mOS). Survival outcomes were analyzed by Kaplan-Meier analysis; factors associated with prognosis were identified by a C...

Wang(L),Qin(R),Liu(H),Zhao(W),Dong(J) J Ultrasound Med 2026-09-11

...MOS-SS), hospital anxiety and depression scale (HADS), and Norfolk quality of life-diabetic neuropathy (Norfolk QoL-DN)....

Moreno-Ligero(M),Dueñas(M),Failde(I),Del P... Am J Phys Med Rehabil 2026-05-01

...mos (T2). Within-group improvements ( P < 0.05) were statistically significant for body mass index and physical functio...

Chan(SL),Breder(V),Shao(YY),Tai(D),Waked(I... Liver Cancer 2026-06-00

...mOS) and landmark survival (12 and 24 months) and secondary outcomes were clinicodemographic characteristics, treatment ...

Shah(H),Sabhahit(GG),Patley(R),Hegde(PR),S... Indian J Psychol Med 2026-03-00

...MOs), community health officers (CHOs), and field-level workers (FLWs) of India. Between October 2022 and June 2024, the...